Federica Miglietta

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Neoadjuvant Chemotherapy

Squamous Cell Carcinoma

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical pathology

Exploration of targeted anti-tumor therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Gene-expression assays to tailor adjuvant endocrine therapy for HR+/HER2- breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Grazia Maria Vernaci, Edoardo Vincenzo Savarino, Ilaria Patuzzi, Sonia Facchin, Fabiana Zingone, Davide Massa, Giovanni Faggioni, Tommaso Giarratano, Federica Miglietta, Gaia Griguolo, Angelo Paolo Dei Tos, Marcello Lo Mele, Elisa Gasparini, Giancarlo Bisagni, Valentina Guarneri, Maria Vittoria Dieci
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy. The oncologist (2023)
Federica Miglietta, Valentina Carraro, Ottavia Amato, Gaia Griguolo, Michele Bottosso, Giada Munari, Giovanni Zarrilli, Marcello Lo Mele, Caterina Barbieri, Angelo Paolo Dei Tos, Valentina Guarneri, Maria Vittoria Dieci, Angelo Paolo Dei Tos
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study. Journal of clinical pathology (2023)
Federica Miglietta, Moira Ragazzi, Bethania Fernades, Gaia Griguolo, Davide Massa, Fabio Girardi, Michele Bottosso, Alessandra Bisagni, Giovanni Zarrilli, Francesca Porra, Daniela Iannaccone, Leocadia Dore, Mariangela Gaudio, Giacomo Santandrea, Angelo Paolo Dei Tos, Marcello Lo Mele, Rita De Sanctis, Alberto Zambelli, Giancarlo Bisagni, Valentina Guarneri, Maria Vittoria Dieci
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Federica Miglietta, Maria Silvia Cona, Maria Vittoria Dieci, Valentina Guarneri, Nicla La Verde
An overview of immune checkpoint inhibitors in breast cancer. Exploration of targeted anti-tumor therapy 1 (6) (2020)
Federica Miglietta, Maria Vittoria Dieci, Vassilena Tsvetkova, Gaia Griguolo, Grazia Vernaci, Alice Menichetti, Giovanni Faggioni, Tommaso Giarratano, Eleonora Mioranza, Elisa Genovesi, Enrico Cumerlato, Michele Bottosso, Tania Saibene, Silvia Michieletto, Marcello Lo Mele, Pierfranco Conte, Valentina Guarneri
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer. The oncologist 25 (9) (2020)